Rapid analysis of docetaxel in human plasma by tandem mass spectrometry with on-line sample extraction

被引:32
作者
Grozav, AG
Hutson, TE
Zhou, X
Bukowski, RM
Ganapathi, R
Xu, Y
机构
[1] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA
[2] Cleveland Clin Fdn, Clin Pharmacol Lab, Expt Therapeut Program, Taussig Canc Ctr, Cleveland, OH 44195 USA
关键词
docetaxel; Taxotere((R)); tandem mass spectrometry; on-line extraction;
D O I
10.1016/j.jpba.2004.05.014
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A simple, rapid, and sensitive analytical method for the measurement of docetaxel in human plasma was developed and validated. The method is based on positive electrospray ionization tandem mass spectrometry (ESI+-MS-MS) with on-line sample extraction. It uses paclitaxel as internal standard for calibration. The on-line sample extraction minimizes sample handling and is readily adopted for automation. Quantitation of plasma docetaxel was done by the multiple reaction monitoring (MRM) mode. The method had a linear calibration range of 1.00-3000 ng/mL with a correlation coefficient >0.9999. The limit of quantitation (LOQ) for docetaxel in plasma was 1.00 ng/mL. The on-line extraction recovery of docetaxel was between 86.1-94.7%, with %CV less than or equal to 6.1%. This method has high accuracy (90.1-96.3%), and excellent intra-assay (0.6-3.8%) and inter-assay (2.0-5.7%) precision. Its applicability to clinical samples was demonstrated by measuring patient plasma samples after treatment of weekly docetaxel at 25 mg/m(2) as 60-min infusion. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:125 / 131
页数:7
相关论文
共 30 条
[1]  
Aapro M, 2001, ANTI-CANCER DRUG, V12, pS1
[2]  
Ardiet CJ, 1999, INVEST NEW DRUG, V17, P325
[3]  
BISSERY M C, 1992, Proceedings of the American Association for Cancer Research Annual Meeting, V33, P443
[4]  
BISSERY MC, 1991, CANCER RES, V51, P4845
[5]   DOCETAXEL (TAXOTERE(R)) - A REVIEW OF PRECLINICAL AND CLINICAL-EXPERIENCE .1. PRECLINICAL EXPERIENCE [J].
BISSERY, MC ;
NOHYNEK, G ;
SANDERINK, GJ ;
LAVELLE, F .
ANTI-CANCER DRUGS, 1995, 6 (03) :339-355
[6]   Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer [J].
Chan, S ;
Friedrichs, K ;
Noel, D ;
Pintér, T ;
Van Belle, S ;
Vorobiof, D ;
Duarte, R ;
Gil, MG ;
Bodrogi, I ;
Murray, E ;
Yelle, L ;
von Minckwitz, G ;
Korec, S ;
Simmonds, P ;
Buzzi, F ;
Mancha, RG ;
Richardson, G ;
Walpole, E ;
Ronzoni, M ;
Murawsky, M ;
Alakl, M ;
Riva, A ;
Crown, J .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) :2341-2354
[7]   Rapid high-performance liquid chromatographic determination of docetaxel (Taxotere) in plasma using liquid-liquid extraction [J].
Ciccolini, J ;
Catalin, J ;
Blachon, MF ;
Durand, A .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2001, 759 (02) :299-306
[8]  
DAVIS TH, 1998, P AN M AM SOC CLIN, V17, pA239
[9]   The taxoids - Comparative clinical pharmacology and therapeutic potential [J].
Eisenhauer, EA ;
Vermorken, JB .
DRUGS, 1998, 55 (01) :5-30
[10]   Simple and sensitive high-performance liquid chromatography method for the determination of docetaxel in human plasma or urine [J].
Garg, MB ;
Ackland, SP .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2000, 748 (02) :383-388